|
|
|
|
Office Locations:
|
1600 Amphitheatre Parkway
Mountain View, CA 94043
Phone: 650-253-0000
| | |
|
|
|
- Early
- Expansion
- Growth
- Seed
|
|
|
|
Energy & Clean Tech
Information Technology
Life Sciences & Healthcare
Software & Internet
Storage & Hardware
|
|
|
|
Founded March of 2009, Google Ventures (GV) is broadly interested in startups in industries including consumer Internet, software, hardware, clean-tech, bio-tech, health care and others. Google Ventures aims to invest up to $200 million a year, with deal sizes ranging from seed investments as small as a hundred thousand dollars to late-stage investments of tens of millions of dollars. GV has invested in more than 300 companies that push the edge of what's possible. Google Ventures is limiting its investment activities to companies within North America at this time. The Partners consider a broad range of industries, including consumer Internet, software, hardware, clean-tech, bio-tech and health care. Google Ventures also plans to start an incubator program called Startup Lab where companies that are just getting started or building a presence in Silicon Valley can work, surrounded by other Google Ventures entrepreneurs. The firm has 400 active portfolio companies.
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
|
|
| Name | |
| |
Title | |
|
| Andy Wheeler | |
| |
General Partner | |
| Anika Gupta | |
PhD | |
Principal | |
| Dave Munichiello | |
| |
General Partner | |
| David Krane | |
| |
CEO & Managing Partner | |
| Graham Spencer | |
| |
General Partner | |
|
|
|
|
Date
|
Name
|
State
|
Amount
|
Stage
|
04/25/2024
|
Cerevance
|
MA
|
$47,000,000
|
Series B-1 Extension
|
04/25/2024
|
Midi Health
|
CA
|
$60,000,000
|
Series B
|
04/09/2024
|
Alethea
|
|
$20,000,000
|
Series B
|
04/03/2024
|
Home From College
|
OR
|
$5,400,000
|
Seed
|
02/23/2024
|
Fabric Health
|
NY
|
$60,000,000
|
Series A
|
02/20/2024
|
Oula
|
NY
|
$28,000,000
|
Series B
|
02/13/2024
|
Areteia Therapeutics
|
NC
|
$75,000,000
|
Series A
|
01/28/2024
|
Granata Bio
|
MA
|
$14,000,000
|
Series A
|
12/19/2023
|
Lightmatter
|
MA
|
$155,000,000
|
Series C-2
|
12/04/2023
|
Seismic Therapeutic
|
MA
|
$121,000,000
|
Series B
|
11/01/2023
|
Gate Bioscience
|
CA
|
$60,000,000
|
Series A
|
10/24/2023
|
Censys
|
MI
|
$75,000,000
|
Venture Debt & Equity
|
10/13/2023
|
ROME Therapeutics
|
MA
|
$149,000,000
|
Series B
|
10/12/2023
|
Scope3
|
NY
|
$20,000,000
|
Series B
|
09/18/2023
|
Nimbus Therapeutics
|
MA
|
$210,000,000
|
|
07/17/2023
|
SpeedyBrand
|
CA
|
$2,500,000
|
|
06/30/2023
|
Speakeasy
|
CA
|
$11,000,000
|
Pre-seed and Seed
|
06/29/2023
|
Typeface
|
CA
|
$100,000,000
|
Series B
|
06/20/2023
|
Caraway Health
|
NY
|
$16,750,000
|
Series A
|
05/31/2023
|
Lightmatter
|
MA
|
$154,000,000
|
Series C
|
|
|
|
|
|
|
|
